世界の生体吸収性血管スキャホールド市場2022-2029:用途別(末梢動脈、冠動脈)、エンドユーザー別、地域別

【英語タイトル】Global Bioresorbable Vascular Scaffold Market Size study & Forecast, by Application (Peripheral Artery, Coronary Artery), by End User (Hospitals, Others) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW22DV030)・商品コード:BZW22DV030
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年11月30日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社は、2021年におよそXX億ドルであった世界の生体吸収性血管スキャホールド市場規模が、2022年から2029年の間にXX%以上成長すると予測しています。当調査資料は、生体吸収性血管スキャホールドの世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、用途別(末梢動脈、冠動脈)分析、エンドユーザー別(病院、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなど、以下の構成でまとめております。なお、当書には、Meril Life Sciences、Abbott、Cook Medical、Boston Scientific Corporation、W.L. Gore & Associates, Inc.、Medtronic、Stentys SA、MAQUET Holding B.V. & Co. KG (Getinge AB)、B. Braun Melsungen AG、Terumo Corporationなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の生体吸収性血管スキャホールド市場規模:用途別
- 末梢動脈における市場規模
- 冠動脈における市場規模
・世界の生体吸収性血管スキャホールド市場規模:エンドユーザー別
- 病院における市場規模
- その他エンドユーザーにおける市場規模
・世界の生体吸収性血管スキャホールド市場規模:地域別
- 北米の生体吸収性血管スキャホールド市場規模
- ヨーロッパの生体吸収性血管スキャホールド市場規模
- アジア太平洋の生体吸収性血管スキャホールド市場規模
- 中南米の生体吸収性血管スキャホールド市場規模
- その他地域の生体吸収性血管スキャホールド市場規模
・競争分析
・調査プロセス

Global Bioresorbable Vascular Scaffold Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The Bioresorbable Vascular Scaffold (BVS) is a non-metallic mesh tube that is generally used in the treatment of a narrowed artery. The BVC completely gets absorbed by the body leaving no foreign material. Factors such as the growing geriatric population and increasing incidences of target diseases such as rheumatic heart disease, coronary heart disease, peripheral arterial disease, cerebrovascular disease, congenital heart disease, and pulmonary embolism are driving the global market growth.

According to the World Health Organization (WHO), it was estimated that approximately 17.9 million people worldwide die every year because of cardiovascular diseases. Therefore, the high prevalence of CVDs is propelling the demand for Bioresorbable Vascular Scaffold, which, in turn, augments the market growth across the globe. In addition, rising technological advancements and a robust product pipeline are presenting lucrative opportunities for growth in the market during the forecast period. However, lack of awareness about bioresorbable vascular scaffolds and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioresorbable Vascular Scaffold Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the presence of skilled professionals and growing investment in R&D activities. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising expenditure on healthcare, as well as growing incidences of target diseases.

Major market players included in this report are:
Meril Life Sciences
Abbott
Cook Medical
Boston Scientific Corporation
W.L. Gore & Associates, Inc.
Medtronic
Stentys SA
MAQUET Holding B.V. & Co. KG (Getinge AB)
B. Braun Melsungen AG
Terumo Corporation

Recent Developments in the Market:
 In May 2021, a study of patients with relatively simple coronary artery lesions unveils that some early promise for a new bioresorbable scaffold such as Firesorb, MicroPort Medical.
 In January 2019, Reva Medical announced the expansion of the company’s commercial operations to seven additional European countries that are Estonia, Poland, Slovakia, Russia, Lithuania, the Czech Republic, and Latvia four new regional distribution partnerships.

Global Bioresorbable Vascular Scaffold Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Peripheral Artery
Coronary Artery

By End User:
Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Bioresorbable Vascular Scaffold Market, by Region, 2019-2029 (USD Billion)
1.2.2. Bioresorbable Vascular Scaffold Market, by Application, 2019-2029 (USD Billion)
1.2.3. Bioresorbable Vascular Scaffold Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bioresorbable Vascular Scaffold Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bioresorbable Vascular Scaffold Market Dynamics
3.1. Bioresorbable Vascular Scaffold Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing geriatric population
3.1.1.2. Increasing incidences of target diseases
3.1.2. Market Challenges
3.1.2.1. Lack of awareness about bioresorbable vascular scaffold
3.1.2.2. High cost is related to the R&D activities
3.1.3. Market Opportunities
3.1.3.1. Rising technological advancements
3.1.3.2. Robust product pipeline
Chapter 4. Global Bioresorbable Vascular Scaffold Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Bioresorbable Vascular Scaffold Market, by Application
6.1. Market Snapshot
6.2. Global Bioresorbable Vascular Scaffold Market by Application, Performance – Potential Analysis
6.3. Global Bioresorbable Vascular Scaffold Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
6.4. Bioresorbable Vascular Scaffold Market, Sub Segment Analysis
6.4.1. Peripheral Artery
6.4.2. Coronary Artery
Chapter 7. Global Bioresorbable Vascular Scaffold Market, by End User
7.1. Market Snapshot
7.2. Global Bioresorbable Vascular Scaffold Market by End User, Performance – Potential Analysis
7.3. Global Bioresorbable Vascular Scaffold Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
7.4. Bioresorbable Vascular Scaffold Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Others
Chapter 8. Global Bioresorbable Vascular Scaffold Market, Regional Analysis
8.1. Bioresorbable Vascular Scaffold Market, Regional Market Snapshot
8.2. North America Bioresorbable Vascular Scaffold Market
8.2.1. U.S. Bioresorbable Vascular Scaffold Market
8.2.1.1. Application breakdown estimates & forecasts, 2019-2029
8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Bioresorbable Vascular Scaffold Market
8.3. Europe Bioresorbable Vascular Scaffold Market Snapshot
8.3.1. U.K. Bioresorbable Vascular Scaffold Market
8.3.2. Germany Bioresorbable Vascular Scaffold Market
8.3.3. France Bioresorbable Vascular Scaffold Market
8.3.4. Spain Bioresorbable Vascular Scaffold Market
8.3.5. Italy Bioresorbable Vascular Scaffold Market
8.3.6. Rest of Europe Bioresorbable Vascular Scaffold Market
8.4. Asia-Pacific Bioresorbable Vascular Scaffold Market Snapshot
8.4.1. China Bioresorbable Vascular Scaffold Market
8.4.2. India Bioresorbable Vascular Scaffold Market
8.4.3. Japan Bioresorbable Vascular Scaffold Market
8.4.4. Australia Bioresorbable Vascular Scaffold Market
8.4.5. South Korea Bioresorbable Vascular Scaffold Market
8.4.6. Rest of Asia Pacific Bioresorbable Vascular Scaffold Market
8.5. Latin America Bioresorbable Vascular Scaffold Market Snapshot
8.5.1. Brazil Bioresorbable Vascular Scaffold Market
8.5.2. Mexico Bioresorbable Vascular Scaffold Market
8.6. Rest of The World Bioresorbable Vascular Scaffold Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Meril Life Sciences
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott
9.2.3. Cook Medical
9.2.4. Boston Scientific Corporation
9.2.5. W.L. Gore & Associates, Inc.
9.2.6. Medtronic
9.2.7. Stentys SA
9.2.8. MAQUET Holding B.V. & Co. KG (Getinge AB)
9.2.9. B. Braun Melsungen AG
9.2.10. Terumo Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



★調査レポート[世界の生体吸収性血管スキャホールド市場2022-2029:用途別(末梢動脈、冠動脈)、エンドユーザー別、地域別] (コード:BZW22DV030)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の生体吸収性血管スキャホールド市場2022-2029:用途別(末梢動脈、冠動脈)、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆